Fortis Healthcare Ltd. (Fortis), India‟s leading healthcare delivery Company, today, announced its consolidated results for the quarter and year ended March 31, 2016 (Q4FY16 and FY16).

The Board of the Company has decided to assess and evaluate a demerger of the diagnostics business of the Company in addition to other options that may be available to unlock and monetize value inherent in this business. The same is subject to finalization by the Board and other stakeholders.

India Business - Key Financial Highlights for the year (FY16)

• Consolidated India Business Revenues at Rs 4,213 Cr, up 7.3%.
• Consolidated Operating EBITDAC for the India Business (EBITDA before net business trust costs) was at Rs 692 Cr, +14.2%, representing a margin of 16.4% versus 15.4% in the previous year.
• Consolidated Operating EBITDA for the India Business was at Rs 235 Cr, up 46%, representing a margin of 5.6% versus a margin of 4.1% in the previous year.

For more information, please contact:
Fortis Healthcare:
Priya Bendre - 77385 70894
priya.bendre@fortishealthcare.com

Read Complete Press Release on below link:

Download Pdf - English